Nature2y
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening
In 1997, the National Institutes of Health convened a Consensus Development Conference on Cystic Fibrosis (CF ... or nonclassical phenotypes (such as congenital bilateral absence of the vas ...
Great Big Story on MSN2d
Claire Wineland's legacy, inspiring life with cystic fibrosis
Explore the courageous journey of Claire Wineland as she shared her life with cystic fibrosis, inspiring many.
US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' next-generation treatment for a rare and progressive genetic disease, the company said on Friday, expanding its dominance in ...
Miss Alabama crowned Miss America, gives national platform to Cystic Fibrosis Foundation
Miss Alabama has been crowned Miss America 2025. Vestavia Hills native Abbie Stockard was crowned Sunday night at the pageant ...
AFP2d
Vertex Announces US FDA Approval of ALYFTREKâ„¢, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis
“Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal levels of CFTR function ...
The Portugal News4d
Slight reduction in births
More than 84,000 newborns were screened for rare diseases in 2024, a decrease of 1,133 babies compared to the previous year, according to the Ricardo Jorge National Health Institute (INSA).